Request Deal Involvement
Dr. Reddy's Laboratories completed the acquisition of nicotine replacement therapy business from Haleon for £500m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
accounting advisors
Grant Thornton
legal advisors
Herbert Smith Freehills Kramer
or
Principals
target
HALEON (NICOTINE BUSINESS)
vendor
HALEON
bidder
DR. REDDY’S LABORATORIES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite